Research programme: glucocorticoid receptor agonists - Matrix Therapeutics

Drug Profile

Research programme: glucocorticoid receptor agonists - Matrix Therapeutics

Alternative Names: Glucocorticoid receptor agonists - Matrix Therapeutics; Research programme: T25 - Matrix Therapeutics; T25 research programme - Matrix Therapeutics

Latest Information Update: 24 Apr 2007

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Matrix Therapeutics
  • Class
  • Mechanism of Action Glucocorticoid receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Inflammation

Most Recent Events

  • 24 Apr 2007 Discontinued - Preclinical for Inflammation in United Kingdom (unspecified route)
  • 18 Apr 2001 Preclinical development for Inflammation in United Kingdom (Unknown route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top